US$ 27.72
igf-1 lr3 description – Research Peptide Buy IGF-1 LR3 (1mg) |
Description
The MASLD/NASH literature on retatrutide is currently in the review-paper stage rather than in primary-trial-readout form

Emerging evidence links type 2 diabetes and AD, conditions that may involve insulin resistance in the brain (reviewed in 53)

The role of neuronal NLRP1 inflammasome in Alzheimer's disease: bringing neurons into the neuroinflammation game

Unfortunately, given the costs that go into clinical trials and the fact that potentially hundreds of thousands of people are already taking these peptides (so theres already a market driving profit), theres a strong possibility that a new robust clinical trial may never be done on BPC-157
